Literature DB >> 28429165

The use of rapid test QuikRead go® Strep A in bacterial pharyngotonsillitis diagnosing and therapeutic decisions.

E Stefaniuk1,2, K Bosacka3, M Wanke-Rytt4, W Hryniewicz5,3.   

Abstract

Group A Streptococci (GAS) are the main causative agents of bacterial pharyngitis, which require antibiotic therapy. Rapid diagnostic tests detecting GAS combined with Centor/McIsaac score enable accurate differential diagnosis (viral vs. bacterial) and prompt commencement of targeted treatment. The aim of this study was to assess the specificity, sensitivity, PPV and NPV of QuikRead go® Strep A (Orion Diagnostica Oy, Finland) recommended for the detection of GAS in pharyngeal swabs. Quick diagnostic test results were compared with physical examination findings, Centor/McIsaac score and results of reference testing (conventional microbial cultures). The study group of 96 participants consisted of 44 women (46%) and 52 men (54%); children aged 3-14 years constituted 46% of the patients. S. pyogenes were cultured from 43 of 96 pharyngeal swabs. Almost half of all positive samples (47%, n = 20) were collected from children aged 3 to 14 years. Positive GAS cultures were confirmed in 33% of patients with Centor/McIsaac score of 2 points, 48% of patients with score of 3, and 50% of patients with score of 4-5. Microbial cultures confirmed the positive results of QuikRead go® Strep A test in 83% of cases. Test specificity and sensitivity were calculated for the entire study group, which were 85% and 91%, respectively. The PPV of the test was 83% and its NPV was 92%. Using quick tests to detect GAS antigens appears a good alternative to conventional microbial diagnosis of strep throat, as it enables making a diagnosis and deciding on treatment plan in one appointment.

Entities:  

Keywords:  Centor/McIsaac score; Rapid test QuikRead go® Strep A; Streptococcal pharyngitis; Streptococcus group A

Mesh:

Substances:

Year:  2017        PMID: 28429165     DOI: 10.1007/s10096-017-2986-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  20 in total

Review 1.  Point-of-care testing in microbiology: the advantages and disadvantages of immunochromatographic test strips.

Authors:  Enno Stürenburg; Ralf Junker
Journal:  Dtsch Arztebl Int       Date:  2009-01-23       Impact factor: 5.594

Review 2.  Rapid diagnostic tests for group A streptococcal pharyngitis: a meta-analysis.

Authors:  Wei Ling Lean; Sarah Arnup; Margie Danchin; Andrew C Steer
Journal:  Pediatrics       Date:  2014-09-08       Impact factor: 7.124

Review 3.  The Group A Streptococcal Carrier State Reviewed: Still an Enigma.

Authors:  Gregory P DeMuri; Ellen R Wald
Journal:  J Pediatric Infect Dis Soc       Date:  2014-04-30       Impact factor: 3.164

4.  A comparison of the BioStar Strep A OIA rapid antigen assay, group A Selective Strep Agar (ssA), and Todd-Hewitt broth cultures for the detection of group A Streptococcus in an outpatient family practice setting.

Authors:  A P Hart; L L Buck; S Morgan; S Saverio; J C McLaughlin
Journal:  Diagn Microbiol Infect Dis       Date:  1997-11       Impact factor: 2.803

5.  The validity of a sore throat score in family practice.

Authors:  W J McIsaac; V Goel; T To; D E Low
Journal:  CMAJ       Date:  2000-10-03       Impact factor: 8.262

Review 6.  Diagnosis of strep throat in adults: are clinical criteria really good enough?

Authors:  Alan L Bisno; Garnet S Peter; Edward L Kaplan
Journal:  Clin Infect Dis       Date:  2002-06-19       Impact factor: 9.079

7.  Large-scale validation of the Centor and McIsaac scores to predict group A streptococcal pharyngitis.

Authors:  Andrew M Fine; Victor Nizet; Kenneth D Mandl
Journal:  Arch Intern Med       Date:  2012-06-11

Review 8.  Rapid antigen group A streptococcus test to diagnose pharyngitis: a systematic review and meta-analysis.

Authors:  Emily H Stewart; Brian Davis; B Lee Clemans-Taylor; Benjamin Littenberg; Carlos A Estrada; Robert M Centor
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

9.  Centor criteria in children in a paediatric emergency department: for what it is worth.

Authors:  Inge Roggen; Gerlant van Berlaer; Frans Gordts; Denis Pierard; Ives Hubloue
Journal:  BMJ Open       Date:  2013-04-22       Impact factor: 2.692

10.  Role of rapid antigen detection test for the diagnosis of group-A beta-hemolytic streptococcus in patients with pharyngotonsillitis.

Authors:  Bernardo Cunha Araujo Filho; Rui Imamura; Luiz Ubirajara Sennes; Flávio Akira Sakae
Journal:  Braz J Otorhinolaryngol       Date:  2006 Jan-Feb
View more
  5 in total

1.  Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation.

Authors:  Hannah Fraser; Daniel Gallacher; Felix Achana; Rachel Court; Sian Taylor-Phillips; Chidozie Nduka; Chris Stinton; Rebecca Willans; Paramjit Gill; Hema Mistry
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

2.  Detection of group a Streptococcus in pharyngitis by two rapid tests: comparison of the BD Veritor™ and the QuikRead go® Strep A.

Authors:  Maya Azrad; Elena Danilov; Sivan Goshen; Orna Nitzan; Avi Peretz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-03-09       Impact factor: 3.267

Review 3.  The next generation of rapid point-of-care testing identification tools for ventilator-associated pneumonia.

Authors:  Guillaume Millot; Benoit Voisin; Caroline Loiez; Frédéric Wallet; Saad Nseir
Journal:  Ann Transl Med       Date:  2017-11

4.  Comparison of Centor and McIsaac scores in primary care: a meta-analysis over multiple thresholds.

Authors:  Brian H Willis; Dyuti Coomar; Mohammed Baragilly
Journal:  Br J Gen Pract       Date:  2020-03-26       Impact factor: 5.386

Review 5.  Diagnostic Methods, Clinical Guidelines, and Antibiotic Treatment for Group A Streptococcal Pharyngitis: A Narrative Review.

Authors:  Zahid Mustafa; Masoumeh Ghaffari
Journal:  Front Cell Infect Microbiol       Date:  2020-10-15       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.